- Home
- KNSA vs LADR Comparison
KNSA vs LADR Comparison
Compare KNSA & LADR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- LADR
- Stock Information
- Founded
- KNSA 2015
- LADR 2008
- Country
- KNSA United Kingdom
- LADR United States
- Employees
- KNSA N/A
- LADR N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- LADR Real Estate Investment Trusts
- Sector
- KNSA Health Care
- LADR Real Estate
- Exchange
- KNSA Nasdaq
- LADR Nasdaq
- Market Cap
- KNSA 1.6B
- LADR 1.5B
- IPO Year
- KNSA 2018
- LADR 2014
- Fundamental
- Price
- KNSA $23.09
- LADR $11.48
- Analyst Decision
- KNSA Strong Buy
- LADR Buy
- Analyst Count
- KNSA 6
- LADR 6
- Target Price
- KNSA $37.17
- LADR $13.29
- AVG Volume (30 Days)
- KNSA 684.1K
- LADR 512.0K
- Earning Date
- KNSA 04-22-2025
- LADR 04-24-2025
- Dividend Yield
- KNSA N/A
- LADR 8.01%
- EPS Growth
- KNSA N/A
- LADR 6.17
- EPS
- KNSA N/A
- LADR 0.86
- Revenue
- KNSA $423,239,000.00
- LADR $271,184,000.00
- Revenue This Year
- KNSA $37.21
- LADR $9.11
- Revenue Next Year
- KNSA $1.38
- LADR $8.48
- P/E Ratio
- KNSA N/A
- LADR $13.35
- Revenue Growth
- KNSA 56.60
- LADR 6.98
- 52 Week Low
- KNSA $16.56
- LADR $10.21
- 52 Week High
- KNSA $28.15
- LADR $12.48
- Technical
- Relative Strength Index (RSI)
- KNSA 60.12
- LADR 45.65
- Support Level
- KNSA $22.62
- LADR $11.41
- Resistance Level
- KNSA $23.42
- LADR $11.64
- Average True Range (ATR)
- KNSA 0.75
- LADR 0.20
- MACD
- KNSA -0.01
- LADR -0.02
- Stochastic Oscillator
- KNSA 68.88
- LADR 31.71
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About LADR Ladder Capital Corp
Ladder Capital Corp is an internally-managed real estate investment trust that is in commercial real estate finance. The company originates and invests in a diverse portfolio of commercial real estate and real estate-related assets, focusing on senior secured assets. The company's investment activities include: (i) Primary business of originating senior first mortgage fixed and floating rate loans collateralized by commercial real estate with flexible loan structures; (ii) owning and operating commercial real estate, including net leased commercial properties; and (iii) investing in investment-grade securities secured by first mortgage loans on commercial real estate. The company has three reportable segments include loans: which derives maximum profit; securities; and real estate.